Genflow Biosciences PLC is a preclinical biotechnology company focused on developing innovative biological interventions aimed at tackling the effects of aging, potentially slowing or halting the aging process and reducing the incidence of age-related diseases and thereby increasing life span... Show more
Industry Biotechnology
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| TOVIX | 15.32 | 0.19 | +1.26% |
| American Beacon IMC Int Small Cap R5 | |||
| HWMAX | 45.66 | 0.55 | +1.22% |
| Hotchkis & Wiley Mid-Cap Value A | |||
| HIACX | 47.19 | 0.02 | +0.04% |
| Hartford Capital Appreciation HLS IA | |||
| AMCPX | 38.13 | -0.04 | -0.10% |
| American Funds AMCAP A | |||
| INIYX | 16.38 | -0.25 | -1.50% |
| VanEck International Investors Gold Y | |||
A.I.dvisor tells us that GENFF and APLIF have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GENFF and APLIF's prices will move in lockstep.
| Ticker / NAME | Correlation To GENFF | 1D Price Change % | ||
|---|---|---|---|---|
| GENFF | 100% | N/A | ||
| APLIF - GENFF | 27% Poorly correlated | +12.73% | ||
| TOVX - GENFF | 25% Poorly correlated | +2.65% | ||
| VRCA - GENFF | 23% Poorly correlated | +2.36% | ||
| SGMT - GENFF | 10% Poorly correlated | +9.41% | ||
| OCS - GENFF | 6% Poorly correlated | +1.39% | ||
More | ||||